Wenzhou Kangning Hospital Co., Ltd. (2120.HK)
- Previous Close
9.170 - Open
9.160 - Bid 9.300 x --
- Ask 9.310 x --
- Day's Range
9.160 - 9.400 - 52 Week Range
8.270 - 15.900 - Volume
8,100 - Avg. Volume
48,854 - Market Cap (intraday)
665.702M - Beta (5Y Monthly) -0.09
- PE Ratio (TTM)
9.68 - EPS (TTM)
0.950 - Earnings Date Mar 28, 2025
- Forward Dividend & Yield 0.60 (6.58%)
- Ex-Dividend Date Oct 16, 2024
- 1y Target Est
--
Wenzhou Kangning Hospital Co., Ltd., together with its subsidiaries, operates a network of healthcare facilities in the People's Republic of China. The company provides psychiatric specialty care and elderly rehabilitation services. It is also involved in property leasing and management; provision of hospital management, medical services, technology, and nursing care services; drug retail and pharmaceutical retail; and equity investments activities. The company was formerly known as Wenzhou City Kangning Psychiatric Rehabilitation Hospital and changed its name to Wenzhou Kangning Hospital Co., Ltd. in October 2014. Wenzhou Kangning Hospital Co., Ltd. was founded in 1996 and is headquartered in Wenzhou, the People's Republic of China.
www.knhosp.cn4,869
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 2120.HK
View MorePerformance Overview: 2120.HK
Trailing total returns as of 5/21/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 2120.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 2120.HK
View MoreValuation Measures
Market Cap
663.53M
Enterprise Value
1.59B
Trailing P/E
9.61
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.38
Price/Book (mrq)
0.50
Enterprise Value/Revenue
0.89
Enterprise Value/EBITDA
11.12
Financial Highlights
Profitability and Income Statement
Profit Margin
3.97%
Return on Assets (ttm)
3.02%
Return on Equity (ttm)
3.66%
Revenue (ttm)
1.65B
Net Income Avi to Common (ttm)
65.61M
Diluted EPS (ttm)
0.950
Balance Sheet and Cash Flow
Total Cash (mrq)
269.69M
Total Debt/Equity (mrq)
89.70%
Levered Free Cash Flow (ttm)
-188.37M